The cash burn here is crazy. Admin and staffing costs are way too high. Revenue is not catching up quickly enough. Add to that the low hurdles that directors, management and staff have to hit for more free shares and options.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025